United States: DC Metro Area

Firms: litigation

  • Covington & Burling LLP
  • Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 
  • Fish & Richardson
  • Kirkland & Ellis LLP
  • Latham & Watkins LLP
  • Paul Hastings LLP
  • Williams & Connolly LLP 
  • Adduci, Mastriani & Schaumberg, LLP
  • Arnold & Porter Kaye Scholer LLP
  • Fisch Sigler LLP
  • Gibson Dunn & Crutcher LLP
  • Goodwin Procter LLP
  • McDermott Will & Emery
  • Paul Weiss Rifkind Wharton & Garrison LLP
  • Rothwell, Figg, Ernst & Manbeck, PC
  • Sidley Austin LLP
  • Sterne, Kessler, Goldstein & Fox PLLC 
  • Venable LLP
  • Wilmer Cutler Pickering Hale and Dorr LLP
  • Winston & Strawn LLP 
  • Akin Gump Strauss Hauer & Feld LLP
  • Baker Botts LLP
  • BakerHostetler
  • Banner Witcoff
  • Blank Rome LLP 
  • Buchanan Ingersoll & Rooney PC
  • Cooley LLP
  • Dentons
  • King & Spalding LLP
  • Mayer Brown
  • Morgan, Lewis & Bockius LLP
  • Morrison & Foerster LLP
  • Oblon 
  • Perkins Coie LLP
  • Pillsbury Winthrop Shaw Pittman LLP
  • Steptoe & Johnson LLP
  • Weil Gotshal & Manges LLP

Firms: prosecution

Firms: transactions

Adduci, Mastriani & Schaumberg, LLP

No other firm compares with Adduci, Mastriani & Schaumberg when it comes to ITC experience. It draws on decades of practice at the intersection of intellectual property and international trade to guide clients and support premier IP outfits around the country as they engage in battle in this forum. The team recently secured a win for LG Energy Solution in a major trade secret case; its forensic probing exposed the respondent’s extensive destruction of evidence, which was crucial to the win.

Akin Gump Strauss Hauer & Feld LLP

Akin Gump has what it takes to prevail in bet-the-company patent litigation and is a trusted ally of high-technology and life sciences industry leaders and other key stakeholders in the innovative community, such as Unified Patents, a member-based organisation focused on deterring the number of NPE assertions in key technology areas. Cono Carrano is representing Unified Patents against the Korea Advanced Institute of Science and Technology and Korean Broadcasting System in challenging a patent directed to video compression techniques; his petition for inter partes review was granted by the PTAB which, in its subsequent final written decision, found multiple claims of the challenged patent to be unpatentable. The firm’s top gun in DC, Carrano has impeccable ITC credentials and recently resolved an investigation with a favourable settlement on behalf of VIZIO, against which Innovative Foundry Technologies asserted several patents relating to semiconductor and integrated circuit technologies. With him on this was David Vondle, another experienced ITC and PTAB lead counsel. Vondle is listed in two IAM Patent 1000 tables this year, having retained his litigation placement and earned inclusion on the transactions list; deal making is a significant component of his practice, his advocacy skill being of great benefit in negotiations. Andrew Holtman has a facility for post-grant proceedings and has considerably amped up Akin Gump’s PTAB activities since coming on board in late 2019. His combination of technical talent – he earned his PhD in molecular genetics at Rutgers University, where he also worked as a research fellow – expertise in coordinating multi-jurisdictional matters and presentation abilities is a huge plus for the group.

Arnold & Porter Kaye Scholer LLP

High-stakes patent litigation is meat and drink to Arnold & Porter, which has built up a real head of steam following victory after victory. Many of these have been delivered by Matthew Wolf, “one of the best you’ll ever see on his feet in the courtroom”: “He is a wonderful first-chair trial lawyer and appellate advocate who can adapt quickly as matters evolve.” Recent highlights include a complete jury win invalidating the patent claims brought by bioMerieux against clients Hologic and Grifols – claims which were anticipated by Hologic and Grifols’s earlier work developing market-leading assays for screening the worldwide blood supply for disease. Wolf also achieved a full victory in a closely followed biotechnology case in which Amgen sought billions in damages and a permanent injunction against the sale of clients Sanofi and Regeneron’s cholesterol-reducing drug Praluent. In this, he convinced the jury that two of the five patent claims asserted were invalid and had post-trial motions granted finding the other claims invalid for lack of enablement; this was upheld by the Federal Circuit in February 2021. No lone wolf by nature, he recognises the value of teamwork and collaboration, and leans on all the right people. Jennifer Sklenar is a valued colleague locally with whom he partnered on the Hologic matter; a “responsive, knowledgeable and dedicated lawyer with an excellent grasp of technology as well as trial skill”, the IP group co-chair debuts in the IAM Patent 1000 for 2021. She earns further praise for “finding solutions that are compatible with wider business strategy”. Arnold & Porter also provides extensive representation in patent prosecution and associated contentious matters, with David Marsh the centre of gravity for this practice. He represents Bayer in prosecuting patents that are critical to the protection of key DNA breakthroughs in the field of plant genetics. Major strings to his bow – and valuable ones in connection with the Bayer work – are his proficiency in both US post-issuance proceedings and European oppositions, and his all-round global strategic IP percipience. There’s yet more on offer at the firm, which has additionally cracked the code of patent and technology commercialisation. Co-leading operations is this area is Susan Hendrickson, a smooth broker of life sciences and high-technology deals. She recently represented the American Red Cross in connection with joint venture, licensing and services agreements with OneBlood to form ARC-One Solutions, a software company focused on the management of blood supplies. Joining her in the guide this year is life sciences ace Kristen Riemenschneider, who provides vital assistance to companies engaging in US government-funded R&D. “Kristen does a fantastic job overseeing valuable and complex transactions. Extremely smart and a tough negotiator who handles pressure well, she is an essential deal team member with exceptional industry knowledge.”

Baker Botts LLP

Ideally placed to weather uncertainty in the market, thanks to the breadth of its patent capabilities, Baker Botts maintains a large group of versatile lawyers who stay sharp in multiple areas of patent practice and can pivot with agility when needed. Regardless of the economic situation, the firm draws immense strength from its well-roundedness and attracts prestigious patrons with its promise of a fulsome service. Helping it to deliver on this resoundingly is the ambidextrous Luke Pedersen, who provides insightful opinions, prosecutes extensively, litigates and closes deals for the likes of Brother Industries; he recently filed an ITC case for the Japanese multinational taking aim at 30-plus companies in the United States and China that are allegedly infringing Brother’s toner cartridge technology patents. With him on this is Lisa Kattan, DC IP group chair and leader of the ITC practice. A former senior investigative attorney at the ITC, Kattan has insider knowledge which hones her strategic focus. Michael Sartori is the other linchpin in DC and a prosecution maestro who builds longstanding relationships based on trust, quality and business-aligned outcomes.


BakerHostetler’s national patent offering is supremely well resourced and well balanced: the firm maintains a substantial group of specialists (many with industry and in-house experience) and displays an equal affinity for prosecution, litigation and transactions. With representatives in the DC rankings from all three branches of the practice, the local office is a persuasive one-stop shop. On the prosecution side, electrical, mechanical and computer science team co-leader Kenneth Sheehan and life sciences group co-head Hussein Akhavannik between them support companies across the technological spectrum. Both have major clients for which their versatility adds tremendous value: Sheehan acts for Sinclair Broadcast Group, one of the United States’ largest and most diversified television broadcasting companies, procuring and maintaining patents worldwide, monitoring competitors and advising on licensing and enforcement matters; while Akhavannik covers similar ground for Fresenius Kabi USA. Another rangy professional, Tayan Patel has a background in electrical and chemical engineering, giving a diverse look to his client base. The former USPTO examiner knows how to take patent applications through to successful grant efficiently and with the minimum of fuss, making him a great fit for companies looking to grow their portfolios quickly; mature transactional skills also set him apart. Robert Hails heads the litigation fight card: “Bob has the technical expertise to properly analyse patents and infringement claims, and the practical ability to put them into real-world scenarios and contexts that are readily understandable to judges. He is smart, efficient, good on strategy and tactics, down to earth and very easy to work with.” Another source adds: “We bring him on as soon as we receive a demand letter or threat, even if litigation isn’t imminent. He can quickly debunk the other side’s arguments and we’ve avoided a significant amount of litigation as a result of his early intervention. In the cases he has handled, he’s gotten us some really fantastic results.” The multi-talented Hails continues to prosecute patents for Apple and others, alongside his contentious duties. BakerHostetler stands ready to deploy in all patent litigation forums and, in Cy Walker and William Bergmann, has seasoned experts for ITC and Court of Federal Claims cases respectively.

Banner Witcoff

Banner Witcoff’s USP is its world-class design patents capability – very few competitors in the United States have anything near its levels of know-how in this niche. Robert Katz and Darrell Mottley run the show and produce flawless design patent procurement and enforcement work for prestigious brands such as Nike, which has instructed the firm since 1992. Katz and Mottley are also integral to the utility patent practice, which is relied on for watertight protection by Fortune 500s, solo inventors and everyone in between. Frederic Meeker is a go-to for innovators in the communications field, among others. He takes the lead in representing Comcast, which benefits from his prosecution prowess, superlative post-grant expertise and litigation experience. With such a multi-layered practice, Meeker is brilliant at long-range strategic thinking. Anyone interested in videogames and intellectual property should have Banner Witcoff on their list; in Ross Dannenberg, it has an authority on matters at the intersection of these subjects. He has helped Wargaming.net to develop a portfolio of 20-plus patents encompassing various technologies such as input techniques, user training and player matchmaking for games including World of Tanks. It is clear from the quality of his work and his dedication that he loves what he does. This level of passion is shared by a lot of folks here, which is another hallmark of the firm. John Hutchins gives 110% as a patent litigator and is ready to do battle over any type of technology. He shoulders a huge load for clients such as ZTE Corporation, which he is representing in two matters against Sisvel – one involving 12 patents and the other nine – as well as 12 associated inter partes reviews.

Birch, Stewart, Kolasch & Birch, LLP

Birch, Stewart, Kolasch & Birch dispenses the full suite of patent services, but is best known for its proficiency in prosecution. The boutique has prepared, filed and successfully registered a dizzying number of patents over the past 45 years, giving it vast institutional knowledge of USPTO practice. Adept in all kinds of post-grant proceedings as well as litigation, it protects clients through thick and thin. For a key contact, look to biochemistry PhD MaryAnne Armstrong, who anchors the life sciences practice. She was recently appointed to the EPO’s Standing Advisory Committee, which is testament to her eminent international standing.

Blank Rome LLP 

A trusted guide throughout all phases of the patent lifecycle, Blank Rome fields accomplished litigators and prosecutors in DC, Houston, Philadelphia and New York, who work collaboratively to get things right first time. Zooming in on the prosecution practice, the firm has an aptitude for software patent protection, but also performs adroitly in the electrical engineering and life sciences spaces – the respective focuses of Stephen Soffen and James Brady. Soffen has cultivated a broad view of the patent world through his involvement in prosecution, post-grant, litigation and licensing, making him a sought-after opinion giver and counsellor. Brady also demonstrates impressive range for his pharmaceutical and biotechnology patrons. Between them, they have many decades of experience. On the contentious front, Dipu A Doshi and Salvatore Tamburo spearhead important campaigns, keeping their eyes firmly trained on the prize. One recent victory came in July 2020 with an early summary judgment win defending Oshkosh as a contractor to the US government which was sued for patent infringement by Ideal Innovations and others. Doshi seamlessly transmutes from counsellor and portfolio manager to tenacious litigator and serves his global clients with agility, whatever they need. Tamburo has been to trial on numerous occasions, but often facilitates early wins.

Bookoff McAndrews PLLC

Among the best in the country in its focused domain of patent counselling and prosecution, Bookoff McAndrews has fostered an environment in which egos are checked at the door and teamwork, engagement, responsiveness and fun are prioritised. This brings a real energy to its practice that clients relish – not least in the quality of outcomes achieved: “BoMc provides the best service you could ask for: it’s technical understanding is exemplary, its commitment to excellence unquestionable and its billing transparency and reasonableness on fees commendable.” The firm was designed to a high specification by Les Bookoff and Roland McAndrews, two lawyers who can’t be beaten for portfolio management skill, strategic insight, business acumen or medical device industry knowledge. They have assembled a diverse, high-performing squad that is only getting stronger as newly elected partners such as Jessica Winchester step up their contributions. Propelled into the IAM Patent 1000 on a wave of outstanding feedback, Winchester is “diligent, detail-oriented, efficient, communicative, dependable and incredibly service oriented. When you send instructions her way, you can rest assured they will be carried out to the highest standard without any oversight required”. She is an integral member of a large team doing cutting-edge work for Boston Scientific, other members of which include the two name partners and Dinesh Melwani and Kirsten Johnson, who also garner glowing notices. “Dinesh is clear and concise in his explanations and recommendations, and a great lateral thinker whose broad insight and analysis enhance discussions tremendously.” “Kirsten doesn’t just get what she needs to draft a patent and file it; she talks to her clients about their innovation, the market, the end user, the exit strategy and budgets, and in this way dives deeper than other attorneys. Understanding why you are filing a patent, she writes up claims that your company valuation will benefit from and maps out where you can take things globally.” Reflecting on a recent due diligence project, one source comments: “We were grilled by an investor’s IP attorneys, but Kirsten took over and made them extremely comfortable with our IP position. She never put a foot wrong and turned an intense interrogation into a walk in the park – she doesn’t crack under pressure.” Another “top-notch attorney who deserves all his recognition”, Christopher Agrawal shares many of these attributes and has put them to good use growing the firm’s computer and internet practice. His leadership inspires his colleagues and clients such as Honeywell International, whose aerospace division he supports with the patenting of industrial Internet of Things (IoT) technologies.

Buchanan Ingersoll & Rooney PC

With many former USPTO examiners among its 45 registered practitioners – who collectively have nearly 7,000 patents in active prosecution – Buchanan maintains a rich and vibrant procurement and opinions practice. An added specialisation in post-grant proceedings and litigation gives it the feel of a boutique, but one that offers the advantages of a full-service outfit. The firm has a new face on the prosecution listings this year in Shawn Cage, who co-chairs the electrical group. He acquits himself with distinction supporting the portfolio development of Mastercard Worldwide, a client for which Buchanan’s broad IP horizons are a major boon. Cage does this alongside IP co-chair Charles Wieland, an attorney who guarantees efficiency, cost effectiveness and above all quality. Wieland has an impressive record at the PTAB, too – one which rivals that of top specialists in the group. Taking the lead on mechanical matters, meanwhile, is William Rowland, a stalwart of the practice who has instilled a client and quality-first mentality in the group. Steeped in post-grant know-how – he is an authority on interferences – sophisticated strategist and advocate Todd Walters heads the USPTO contested proceedings practice, working alongside other high-level contributors including Patrick Keane and Matthew Fedowitz. A percipient patent strategist, Keane understands how to use litigation and America Invents Act (AIA) proceedings, among all other available tools, for the purposes of IP value creation. Fedowitz’s duality as a prosecutor and litigator gives him a skillset fit for successful PTAB representations. For Lloyd Smith, who has fought and won cases in all IP categories, court litigation is the name of the game. He and Fedowitz have teamed up on a number of pharmaceutical cases, giving his recent patent activities a strong life science bent.

Carmichael IP PLLC

Carmichael IP provides a wide range of strategic patent services but, established by former PTAB judges, it manifests a rare faculty for post-grant proceedings. Knowledgeable about AIA trials to a degree that few other firms are, it is a repository of trust for patent owners in urgent need of a win. One of those former judges, James Carmichael – who has also served the USPTO in other capacities – has rich prosecution, post-grant and Federal Circuit experience to draw on, making him a vital strategic sounding board. Stephen Schreiner holds his own in all manner of contentious matters and is gifted at prosecution, portfolio development and other facets of patent practice, making him another discerning choice for wraparound counsel.

Cooley LLP

At the national level, few rivals can claim Cooley’s maturity across the full patent spectrum. A must for holistic support, it attracts high-level clients for which patent rights are pivotal to business. The key contacts for many of these are based in its DC metro area offices, which are home to several current and former practice group leaders. Michael Tuscan, for example, previously served as counselling and prosecution group co-chair and is now the DC partner in charge. A prime pick for biotechnology companies within an acclaimed US and international life sciences practice, Tuscan drafts and prosecutes patents with finesse, while adding tremendous value as a far-sighted strategist and IP commercialisation lawyer. He manages the worldwide IP portfolio of Compass Pathways, which recently became the first pharmaceutical psilocybin company to be listed on a US exchange. Reston’s Scott Talbot has a similarly broad skillset which he applies on behalf of innovative medical technology companies such as Farapulse, which is at the cutting edge of pulsed field ablation therapy for atrial fibrillation; Talbot has built its entire patent portfolio and defended IP diligence by investors in several financing rounds. On the contentious front, DC-based Stephen Smith chairs the firmwide IP litigation practice and makes his IAM Patent 1000 debut for 2021 in recognition of the stellar leadership he brings both to the group and to cross-office litigation teams. He and fellow trial lawyer Erik Milch recently linked up to reverse a jury verdict awarded against long-time client Nintendo, consequential to which loss was an unsuccessful inter partes review in which Nintendo was advised by another firm; that they overturned a jury verdict in Texas in this way is a good measure of their high-calibre advocacy skills.  Cooley’s trial bench has grown stronger with the recent arrival of former Finnegan partner Sanya Sukduang, who brings added pharmaceutical patent litigation firepower. He is representing CSL Bhering in a competitor biologics case with corresponding UK and German litigation and EPO opposition proceedings. Adam Ruttenberg is the local licensing and transactions star.

Covington & Burling LLP

Major technology companies place their faith in Covington & Burling and dial it up for representation in bet-the-farm patent litigations. Its formidable contentious capabilities come courtesy of luminaries such as American College of Trial Lawyers fellow George Pappas; Kevin Collins, whose broad-ranging IP and commercial litigation practice has taken him through nearly 50 trials; and Richard Rainey, who brings top-level in-house experience to the table. For ITC matters of distinction, Covington is incredibly well equipped, with Sturgis Sobin and Alexander Chinoy both specialists in this vital forum. A preferred choice for life sciences mandates, too, it puts Einar Stole and Christopher Sipes onto the playing field for maximum impact. The firm’s deal practice is just as sophisticated, thanks to the captaincy of John Hurvitz, who also co-chairs the life sciences group; he has brokered deals of just about every variety around the world. Meanwhile, settlement negotiations maestro Stuart Irvin ensures that the transactions and litigation practices are well connected.


Dentons has a unique ability to fulfil global patent needs and leverages a vast network and some 600 IP and technology-focused lawyers to superb effect. More than 100 of these are based in offices across the United States, giving innovators exceptional national coverage. Without integration, though, these resources would not have half their value – which is where Song Jung comes in: awesome as global chair of the practice, he has a gift for motivation and gets the entire firm pulling in the same direction. He bears weighty responsibilities for his clients too – most notably LG, for which he handles a docket of over 8,000 US patent matters across its electronics, display and chemical businesses. With him on this is Mark Kresloff, a prosecution expert who has operated at the cutting edge of developments in mobile technologies throughout his career; his work – as well as time spent overseas, including in South Korea – has given him a global IP view. Chemical practice Martin Bruehs likewise has a broad wheelhouse and executes cross-border IP protection and development strategies for life sciences, medical technology and other innovators. He also leans heavily into the litigation practice and recently took the lead in obtaining a favourable settlement for Bodor Laboratories in a patent licensing dispute comprised of two district court actions and an arbitration proceeding against Brickell Biotech and Kaken Pharmaceutical. True-blue litigator Mark Hogge has orchestrated complex patent proceedings in all major forums involving all fields of technology. He brings the heat in the ITC where, alongside Jung, he has recently been representing LG Chem against SK Innovation in a trade secret misappropriation matter relating to batteries for electric vehicles.

Faegre Drinker Biddle & Reath LLP

Nothing is off limits in patent practice for Faegre Drinker, which has the technical might to prosecute and manage large global portfolios in any domain and the contentious muscle to enforce and defend patents against the toughest opponents; its IP and technology lawyers also collaborate with colleagues in other departments to assist clients with their patent-driven commercial dealings. Well known to the life sciences community, the firm has a marquee name in DC in Mercedes Meyer. Showcasing strong commercial instincts, she guides pharmaceutical and biotechnology concerns through the patenting process with a deft touch, always acting in accordance with wider strategic plans and with an eye out for business opportunities. Another compelling reason to call on Faegre Drinker in DC is the presence of Robert Stoll, a former USPTO leader and a lawyer with vast experience at the vanguard of modern IP development.

Fiala & Weaver PLLC

Configured to meet and exceed all prosecution needs, Fiala & Weaver offers the highest quality at a reassuringly sensible price point. Leanly structured and comprised of highly trained, technically accomplished members, the firm deploys state-of-the-art technologies to procure and manage patents with utmost efficiency. Instilling the group with a laser business focus are directors and co-founding partners Thomas Fiala and Jeffrey Weaver. Both elevated strategic thinkers, they have been drawing a growing crowd from the IoT, data encryption and IT automation fields of innovation.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 

The conscientious cultivation of a diverse, inclusive workplace has been crucial to sustained IP success at Finnegan: freely exchanging creative ideas – in the same way that clients do in the innovative process – the lawyers here thrive. Unbelievable depth is another key feature of the group, which handles the gamut of patent assignments across all technological disciplines with exactitude. Global reach is a further selling point: Finnegan’s offices in London, Seoul, Shanghai, Taipei and Tokyo are staffed with likeminded professionals who combine to support clients when and where required. Putting the ensemble’s prosecution activities under the microscope, Finnegan files roughly 3,000 US patents each year and half that number again overseas, with a fantastic hit rate. Newly featured in the IAM Patent 1000 prosecution rankings for 2021 are Jill MacAlpine and Michael Young, both of whom play important roles: organic chemistry PhD MacAlpine captains the patent office practice and, with her broad skillset, is a perfect fit for dynamic life sciences entities innovating across multiple therapeutic areas. Young prosecutes principally in the computer science field and is the lead partner for a top bank whose domestic and international prosecution he oversees. Both are also noteworthy for their contentious expertise, with MacAlpine playing a strong hand in Hatch-Waxman litigation and Young in post-grant proceedings. Few of Finnegan’s lawyers can be easily pigeonholed, which is a great strength of the firm; a multiplicity of purpose is discernible in the practices of Mark Sweet, Adriana Burgy, Yanbin Xu and Gregory Gramenopoulos, who round out the prosecution list. Chairman and former managing partner Sweet undertakes wide-ranging portfolio, counselling and post-grant duties, as does Burgy; Xu litigates and prosecutes with aplomb; and Gramenopoulos excels as a strategic counsellor and licensing negotiator. Working alongside designs authority Elizabeth Ferrill, another multi-talented star, Gramenopoulos represents Google in protecting its innovative graphical user interfaces and icons, as well as product designs for mobile devices. Google is just one of Ferrill’s household-name clients; she also treats Caterpillar and Eli Lilly to an exemplary service. Finnegan’s litigation and post-grant practices have also been cooking in recent years, with contributions coming from a great many lawyers, including Charles Lipsey and Michael Jakes, heavyweights of the firm’s market leading life sciences patent litigation and appellate offerings respectively. Other crack pharmaceutical litigators include James Monroe, Bryan Diner and Barbara Rudolph – the latter a key member of a cross-office Atlanta, DC and Tokyo team that recently achieved a Federal Circuit victory for Kaken Pharmaceuticals and Bausch Health that revived a key patent covering its Jublia product, which the PTAB had declared unpatentable for obviousness. ITC litigation is another Finnegan forte, with Smith Brittingham, Qingyu Yin and Mareesa Frederick forming a high-calibre line-up of Section 337 investigations specialists.  Brittingham and Yin have lately represented SZ DJI Technology, against which Autel Robotics requested an investigation seeking to prevent DJI from selling drones with intelligent operations such as obstacle avoidance; they secured a favourable initial determination from the administrative law judge, following which great success was achieved at the PTAB challenging the asserted claims from all three patents involved in the ITC proceeding. Meanwhile Frederick, together with James Barney and Taipei-based Gary Ma, secured a summary determination of no infringement on behalf of REC Solar Holdings and REC Americas against Hanwha Global Asset Corporation, which sought to exclude REC’s solar cells and modules from importation into the United States, granted by the administrative law judge and adopted by the full ITC. Lionel Lavenue also has ample experience in this forum, as in many others – which is unsurprising, given his handling of some 200 patent cases. In one recent precedential suit, he vacated a $110 million judgment against client TCL Communication, which was sued for patent infringement in the Eastern District of Texas by Ericsson and found to have wilfully infringed – a decision which he had reversed by the Federal Circuit. The wins on the post-grant side also come thick and fast, thanks again to the efforts of many – not least Erika Harmon Arner and Thomas Irving, two celebrities who have demonstrated thought and practice leadership since the passage of the AIA. New to the IAM Patent 1000 for 2021, Joshua Goldberg takes charge of the PTAB practice and has special expertise on inter partes reviews arising in connection with ITC cases. Michael Flibbert’s advocacy and technical talents are frequently on show at the PTAB, as well as in ITC matters and Hatch-Waxman Act litigation. Jeffrey Berkowitz is another Swiss Army knife of a practitioner: with the knowledge and skills of a precision prosecutor, he also makes light work of all types of adversarial proceedings. The versatility of Finnegan’s lawyers helps to create valuable connections between different divisions: Doris Johnson Hines , for example, bridges the litigation and transactions units and has a flair for FRAND issues. Advocacy and deal brokering are likewise twin focuses for Brian Kacedon; he and Hines have been jointly representing a leading automaker in connection with the licensing of SEPs. John Paul’s name reverberates in licensing circles: he is the president-elect of the Licensing Executives Society International. Alongside him, William Pratt is another doyen of Finnegan’s transactions group.

Fisch Sigler LLP

Trial boutique Fisch Sigler believes in the power of diversity, maintains a collaborative culture, practises with civility, makes optimum use of legal technology solutions and offers flexibility on fee arrangements. All these things make it a vital ally in the trenches of high-stakes patent and IP disputes, and contribute to its dynamite record of success. One recent highlight was a settlement for Largan Precision in its long-running dispute with optical lens competitor Ability Opto-Electronics Technology. A genius trial lawyer who does things in the right way and for the right reasons, Alan Fisch continues to stand out even among his fellow gold-tier occupants in the IAM Patent 1000.

Fish & Richardson

World-class IP outfit Fish is scarcely rivalled for global patent prosecution. Leveraging its presence in the United States, Europe and China and an incredibly deep pool of technical and strategic talent, it prosecutes some 5,000-plus US patents and 4,000-plus foreign patents each year. Steering the ship is DC-based patent group leader John Hayden, whose management abilities, instinct for efficiency savings and sophisticated understanding of patent quality make him perfect for the role. Fellow high-level operatives in DC include Nick Jepsen, David Jordan and Phyllis Kristal, each of whom brings something special to the table. In the electrical, computer and medical technology spaces, Jepsen “provides great value in developing invention concepts into patentable intellectual property and writing strong and defensible claim sets; he is highly adept at negotiating with USPTO examiners, too”. Prolific prosecutor Jordan has an amazing success rate in the challenging field of software protection – one which he has absolutely mastered. Mechanical engineering is the metier of Kristal, a senior stateswoman of the firm who joined in 1993 and has been dispensing sage counsel and opinions to a huge number of innovative companies in many sectors ever since. Special attention should also be paid to Fish’s post-issuance proceedings experts, who drive the market’s busiest PTAB practice – and certainly one of the best. The fulcrum around which this turns is Karl Renner, a veteran of hundreds of AIA proceedings and a founding director of the PTAB Bar Association, which he now serves as president elect. Timothy Riffe doubles up as one of Fish’s top ITC litigators and has one of the most sophisticated contentious IP toolkits not just in the firm, but in the country. PTAB Bar Association board member Thomas Rozylowicz and David Holt bring added dynamism to the group, courtesy of their proficient advocacy and technical dexterity. To the latter point, Rozylowicz has impressive engineering experience on his résumé, having directed research into secure communications at the National Security Agency; while former examiner Holt was previously a software engineer in industry. Despite all the wonderful achievements of its prosecution and post-grant divisions, Fish remains best known for its contentious prowess and its indomitable performances in trials, appeals and Section 337 investigations. The headline acts are Michael McKeon and Ruffin Cordell, whose trial seasoning, calmness under pressure, strategic acumen and narrative gifts are behind many genre-defining wins. They are two among several potent ITC lawyers – other notable names being Riffe, Rich Sterba, Andrew Kopsidas and Joseph Colaianni. Sterba has tried more than a dozen cases at the ITC out of nearly 30 investigations he has handled; alongside colleagues in Boston and San Diego, he is currently representing Intuitive Surgical at the ITC and in co-pending inter partes reviews against Ethicon Endo-Surgery in a dispute over robotic surgical systems. Kopsidas and Colaianni also make the difference in this fast-paced forum – the former with his tenacity and efficiency, and the latter with his encyclopaedic procedural knowledge and sparkling presentation. All of Fish’s litigators translate their advocacy into success no matter what the forum. Lauren Degnan hammers out the right results in high-technology suits spanning many district courts, the ITC, the PTAB and the Federal Circuit; as do Christian Chu, a top appellate lawyer; Ahmed Davis, a compelling storyteller; and rising star Adam Shartzer, a “well-organised, thoughtful and effective communicator”.

Foley & Lardner LLP

Foley & Lardner has always emphasised well-roundedness in patent law: it isn’t just chasing the big litigations for prestige or fees (although it handles many), but rather prioritises the provision of a holistic service. Cross-practice expertise is something that many of its leading lights in DC and other offices can justly claim: Stephen Maebius, for example, negotiates prizewinning deals, represents parties in litigation and post-grant proceedings, and supports many clients as a portfolio manager and counsellor. He, Courtenay Brinckerhoff and Michele Simkin form the backbone of a thriving life sciences practice that has all bases covered for pharmaceutical and biotechnology innovators. Brinckerhoff knows which the way the wind is blowing in the industry and tailors her advice accordingly; she undertakes significant prosecution and post-grant assignments. Simkin brings strong leadership to the firmwide IP department, serving as its chair, and also lights the path forward for clients when it comes to procuring, managing and commercialising patents. Eric Sophir, meanwhile, has become an anchor of the electronics practice since he joined in Spring 2020. He operates artfully across the contentious/non-contentious divide, but is at his best designing and executing long-play patent strategies. A vital sounding board on all kinds of patent matters, veteran partner George Quillin is a noted authority on post-grant proceedings and leader of the PTAB practice.

Gardella Grace PA 

Gardella Grace knocks it out of the park when it comes to post-grant proceedings, but is also a discerning choice for a whole range of patent procurement, trade secret protection, IP transactions and litigation tasks. The ensemble’s work for Aon Corporation speaks to its versatility: Greg H Gardella has developed a broad portfolio for the company, whose full IP needs he takes care of. The firm’s representation of medical device company Fulfillium is another case in point; Gardella, with back-up from his team, has obtained patents for it and successfully enforced them against multiple parties in multiple forums. Best known for his PTAB prowess, Gardella has a superlative track record defending companies’ most valuable patents in post-grant proceedings. In all endeavours, he gets robust support from Natalie J Grace, who debuts in the IAM Patent 1000 this year. The pair are recommended for their “down-to-earth, get-the-job-done attitude and complete lack of hubris”. They are also “extremely user friendly for non-lawyers” because “their communication is so easy and clear”. Another newcomer to the listings is Cook Alciati, the firm’s principal litigator.

Gibson Dunn & Crutcher LLP

Gibson Dunn has the moxie to take on and win bet-the-company patent litigations; its phalanx of eminent trial lawyers pursues aggressive strategies to resolve disputes favourably in court or, as is often the case, much earlier. Holding the fort in DC, Brian Buroker is a master tactician and oral advocate who knows what resonates and persuades in district court, ITC and PTAB proceedings. He has been a key member of trial teams representing major clients such as AT&T and a leader of them in other matters of high importance. A good example in this regard is his representation of Allergan in an ITC investigation against Korean company Daewoong Pharmaceutica arising from its import and sale of a botulinum toxin product that was allegedly developed with trade secrets misappropriated from Medytox, Allergan’s licensing partner; in July 2020, the administrative law judge issued a final initial determination in favour of Allergan. When matters go up on appeal, Gibson Dunn has a not-so-secret weapon in Mark Perry, who co-chairs the national appellate and constitutional law group and is key to the firm’s formidability.

Goodwin Procter LLP

Goodwin Procter is impeccably prepared for Section 337 investigations at the ITC, with specialised and well-adapted professionals Patrick McCarthy, Ronald Pabis, Stephen Shahida and Mark Davis on deck. Coming in for special praise, McCarthy impresses for his “dedication, diligence, enthusiasm, constant availability and excellent results in very challenging cases”. He has recently represented large light-emitting diode (LED) display manufacturers, including Glux Visual Effects Tech, which hired him in place of previous counsel for several inter partes reviews. He, Pabis and Shahida have also teamed up to represent Ecoservices in an appeal arising from a jury trial win against Certified Aviation Services. Whichever forum their matters take them to, all four lawyers work with agility and weave together unique stories that cause opponents to shift positions, creating new strategic openings to capitalise on. The firm’s DC office is graced by the presence of other luminaries such as William James and William Jay. One of the top pharmaceutical patent litigators in the capital, James is recommended as a “whip-smart, even-keeled and strategic lawyer with a very strong courtroom presence”; he has “immediate credibility with judges, technical experts and anyone else he comes across”, and “understands how to simplify the science to argue his point”. “Bill also appreciates how to staff matters to ensure budgets are met and takes a very hands-on and collaborative approach.” He works closely with New York’s Elizabeth Holland – a fellow IAM Patent 1000 gold-ranked lawyer – in many Hatch-Waxman litigations. Jay leads the local litigation group and co-chairs the national appellate practice. He’s an award-winning Federal Circuit and Supreme Court lawyer with incredible experience in patent and other IP disputes.

Grüneberg and Myers PLLC 

Rave reviews flood in for this “exceptional boutique”. “I have worked with several firms on patent matters in recent years, but none has been as professional or attentive to our needs as Grüneberg and Myers – frankly, they’re not even close,” reports one source. “It tracks and monitors every aspect of our filings so our executive team has never had to stress about deadlines or decisions – we are automatically reminded when actions are due and receive detailed recommendations on courses of action at each point in the process. The legal advice has been sound and we’ve secured our patents much quicker than we expected to do so. The practitioners there are always available to answer any questions and respond immediately to our needs; they also provide exceptional value for the reasonable cost of their services.” The firm was founded by organic chemistry PhD Kirsten A Grüneberg, who has masterminded continued expansion, rapid growth in business from Asia, success in high-value pharmaceutical projects and the implementation of legal technology to enhance efficiencies. She is joined in the listings this year by co-founder Eric Myers and fellow PhD Richard Chinn – the former recommended for his strategic and business sense and the latter for his deep scientific knowledge.

Harrity & Harrity LLP

“Efficient, timely and cost effective”, Harrity & Harrity is the preferred choice of many when it comes to patent prosecution. A “role model”, it has “implemented some clever procedures and modes of operation, enabling it to consistently deliver work of the very highest standard of quality”. Central to this are the thorough second-attorney review system and uniform writing style championed by founding partners John Harrity and Paul Harrity, who are also responsible for the boutique’s innovation drive, by which large numbers of statistics are tracked so that performance can be precisely measured and improvements implemented. These improvements are often underpinned by technology such as the massive proprietary database that the firm uses to drive intelligent prosecution and its interactive Patent 300 dashboard, which gives clients access to rare insights harvested by the patent analytics group. The software experts here had a busy 2020, developing several new products, such as a patent drafting tool designed to help their attorney colleagues – including the Harrity brothers and Paul Gurzo – focus on patent quality as opposed to more administrative tasks.

Jones Robb PLLC

Dedicated to excellence in patent prosecution and counselling, Jones Robb provides a captivating service whose hallmarks are partner attention, collaboration, flexibility, quality and sensitivity to price. The ensemble astutely leverages technology to carry out its assignments with singular efficiency; things aren’t done in automated fashion, however, thanks to the strategic perspicacity which senior team members such as Susanne Jones, Kevin Robb and Elizabeth Burke apply in their endeavours. Jones prosecutes patents informed by a rich understanding of the competitive marketplaces in which her clients – including leaders in robotic-assisted surgical systems and life sciences solutions – operate. Robb manoeuvres deftly in challenging patenting and legal environments faced, for example, by data processing business solutions companies, and builds coherent, high-value portfolios. Burke protects clients’ crown-jewel patent assets globally for start-ups as they move towards the all-important release of their first products.

King & Spalding LLP

King & Spalding inspires confidence of a win in major patent disputes. It has many seasoned trial lawyers from coast to coast who have proven their mettle in technically demanding cases across the science and engineering spectrum – and who are eager to collaborate across offices to ensure that clients benefit from the right mix of skills and experience. DC-based Stephen Baskin and New York’s Allison Altersohn, for example, form a dynamic pairing and have been jointly representing Delta Air Lines in patent infringement against Sound View Innovations and acting for NCR Corporation against Pendum – a former authorised reseller and service provider for its ATM machines in a multi-layered copyright, trade secrets, breach of contract and tortious interference claim. Well suited to a case such as NCR, Baskin has honed his advocacy skills to a fine point and developed well-rounded IP knowledge through serving as lead counsel in many patent, trademark and copyright litigations. Chris Campbell, meanwhile, has synced up with lawyers in Denver on some of his recent briefs, which include defending Contec Medical Systems in a Northern District of Illinois suit filed by Beijing Choice Limited asserting a patent related to pulse oximetry. With great results to show for it, Campbell has litigated around the country and in the ITC and PTAB. The top specialist for post-grant proceedings, however, is Lori Gordon, who has been working with Silicon Valley lawyers Tom Friel and Jim Brogan in a big competitor shootout in the chemical industry. King & Spalding is outperforming many in the PTAB thanks to Gordon’s efforts and the contributions of many others, including Gerald Flattmann and his New York life sciences colleagues.

Kirkland & Ellis LLP

Primed and ready for any high-stakes district court, ITC or Federal Circuit action, Kirkland & Ellis’s DC patent litigation team has seen and done it all in the patent space. Displaying the firm’s trademark commitment, strategic agility, decisiveness and trial prowess, Gregg LoCascio stands tall as one of the elite patent lawyers not just in the capital, but in the country. So too Edward Donovan, who is distinguished by his adroit navigation of Section 337 proceedings, among other things. He, LoCascio and Paul Brinkman – the most specialised among his colleagues – give the firm a strong presence on the national ITC rankings. In terms of recent highlights, Brinkman has been representing Heineken and affiliates in two ITC cases – and one in the Southern District of New York – adverse to Anheuser-Busch InBev; all three are being coordinated with multiple European actions, making this a great example of the sorts of large-scale, multi-front competitor battles for which Kirkland & Ellis is made. For disputes that go up on appeal, John O’Quinn has the right stuff, as he recently proved in securing an appellate victory for BASF in its ongoing patent enforcement efforts against SNF Holding Company; his reversal of a trial loss by BASF (then represented by another firm) clarified the law on when confidential materials can and cannot constitute invalidating prior art. Kirkland & Ellis’s recent addition of former Oblon practitioner Todd Baker gives it enhanced PTAB capabilities, making its contentious practice even more compelling. Christopher Mizzo also has ample post-grant experience, accumulated in the course of a wide-ranging patent litigation practice that has put him in important roles in bet-the-company cases across all forums.

Latham & Watkins LLP

In DC, Latham & Watkins has amassed many accomplished patent trial lawyers and is a hypercar among its supercar competitors which – geared for big-ticket pharmaceutical and high-technology litigations, ITC investigations and post-grant proceedings – performs well over any road surface. The firm has five representatives in the IAM Patent 1000 gold tier for DC – more than any competitor –  with Maximilian Grant, Michael Morin, Matthew Moore, Adam Perlman and Bert Reiser all scoring top marks. Grant has a gift for inspiring and motivating trial teams to great things. Healthcare and life sciences industry group global co-chair Morin also shows superb leadership, which is just one of the reasons why his clients instruct him on a repeat basis. Moore is a clear-sighted strategist who is well suited to the largest litigation campaigns; Perlman advocates superbly for pharmaceutical originators; and Reiser distinguishes himself as a foremost ITC specialist. Meanwhile, Jamie Underwood, David Frazier, Lawrence Gotts, Tara Elliott and Robert Steinberg each bring special skills and attributes to the mix. Underwood is appreciated for her advocacy and strategic advisory talents, which are on full display in her ITC-focused practice; Frazier has a flair for complex biotechnology suits; Gotts and Elliott have sharp trial skills honed through exposure to a wide variety of IP and non-IP cases; and Steinberg lights the path in PTAB proceedings.

Mayer Brown

Clients and peers alike are nothing less than delighted with the service on offer at Mayer Brown. Partnering with it in the context of a major patent litigation, one source comments: “From the initial introductory meeting to the collection of all pertinent documents and all other trial preparation steps, Jamie Beaber and Mayer Brown have been clear, concise and extremely focused. A lot of attorneys elsewhere speak in legalese and give non-committal advice that leaves issues vague, but this is not the case with Jamie and his team.” Beaber is an integral member of the firm’s potent national patent litigation practice and an anchor in DC alongside celebrated veteran Alan Grimaldi, with whom he works extensively in district court actions. Beaber also has an affinity for ITC matters and leads the Section 337 practice, of which Gary Hnath is a key member. A former president of the ITC Trial Lawyers Association, Hnath is the partner of choice for many Chinese entities litigating in the forum. By all accounts, he is a “high-calibre specialist and an intelligent, diligent, conscientious and responsive lawyer”. His ITC win for Ninestar, with a finding of non-infringement of seven laser toner cartridges asserted by Canon, was recently upheld by the Federal Circuit in a Rule 36 affirmance.

McDermott Will & Emery

“When you need to bring out the big guns in patent litigation, McDermott is the firm to call. The people there – such as Jay Reiziss and Charlie McMahon – are smart and savvy litigators who understand the pressures of in-house attorneys and how to work within the system of the companies they represent. In high-stakes cases, it is essential to have lawyers who know how to be team players, as McDermott’s professionals do.” Reiziss takes centre stage in the firm’s ITC practice and is a dynamic force at the commission, which he knows inside out, having previously served in multiple posts there. His recent achievements include successfully defending Target Corporation on behalf of its indemnitor Feit Electric Company in a case adverse to the University of California (UC) Santa Barbara, which initiated an investigation against Target and multiple other retailers regarding alleged infringement of four patents relating to vintage-style filament LED lightbulbs; a strong defensive case led to the withdrawal of the case by UC. Other high-calibre members of the DC squad include Thomas Steindler, Paul Schoenhard and Nicole Jantzi, who have joined forces to represent Bausch Health US against Mylan Pharmaceuticals in an abbreviated new drug application (ANDA) litigation. Veteran Hatch-Waxman lead counsel and head of the DC IP litigation group Steindler stands out for his “technical expertise, tenacity and consistent ability to outwork and outthink his opponents”. Schoenhard has exhibited his strategic perspicacity and advocacy skill across many forums and in disputes over many types of technology; likewise Jantzi, with whom he frequently collaborates to winning effect. The firm’s prosecution practice is also well developed, ensuring that the litigators don’t hog the limelight. Michael Fogarty maintains a close relationship with Panasonic, for which he manages hundreds of patents. Leading on this with him is Takashi Saito, a former semiconductor engineer and IP specialist for a global electronics manufacturer with a first-hand understanding of the innovation process.

Morgan, Lewis & Bockius LLP

Morgan Lewis has three individuals recommended in the IAM Patent 1000 DC rankings who between them cover a huge amount of ground. In its versatility, the local group is much like the national one; few full-service commercial outfits are as heavily invested in all facets of patent protection, litigation and monetisation as Morgan Lewis. On the prosecution and counselling side, Hosang Lee offers valuable cross-cultural and commercial US-Korean know-how to companies in the high-technology and automotive sectors. His counterpart in the life sciences is pharmacology PhD Robert Smyth, who has vast prosecution experience, keen strategic global vision and abundant post-grant expertise not just in the United States, but in Europe, Asia and Latin America. Eric Namrow is the leading litigator residing in DC and captain of the firmwide ITC practice. He has played crucial roles in 75-plus investigations, two dozen of which have gone to trial, giving him a deep playbook to draw upon for the next challenge.

Morris Manning & Martin LLP

The life sciences is a stronghold for Morris, Manning & Martin, which serves up perspicacious strategic counsel to pharmaceutical and biotechnology companies as they look to protect their competitive advantage and capitalise on their intangible assets for business purposes. In Ping Wang, the ensemble has “one of the most exceptional legal minds on the planet”, according to the clients who line up to sing her praises: “Ping consistently demonstrates the ability to take an idea – whether in a crowded space or not – and develop patent applications that achieve granted status. Her issuance percentage is ridiculously high, making her an extremely productive IP lawyer. She has a clear vision for the service she wants to deliver, along with excellent leadership skills, and has assembled a team whose members have all bought into her relentless approach to patent prosecution.” The breadth of her knowledge is a boon to companies such as Q3 Medical Devices, for which she recently performed pre-IPO due diligence in connection with its listing on the Hong Kong stock exchange and brokered a lucrative licensing deal with Medtronic, alongside handling its entire IP portfolio. By her side is Michael Ye, who has unique talents when it comes to transactions in China. Scientifically gifted and acutely aware of clients’ commercial imperative, Ye never fails to make an impact.

Morrison & Foerster LLP

Morrison & Foerster has several practice leaders, formal and informal, stationed in DC who make essential contributions to what is an outstanding national patent practice. An expert in advanced materials, among other technologies, East Coast prosecution group Jonathan Bockman formulates competitive IP strategies with a deft touch. He is the first port of call for patent procurement matters, portfolio management, IP due diligence and more, including representation in inter partes reviews. He also regularly supports IP litigation – the primary focus of Mark Whitaker, who co-chairs the global practice as well as the firm’s cross-disciplinary IP group. Accustomed to leading – he is also a past AIPLA president – he inspires and motivates his team to achieve major feats in district courts and the ITC, a forum which he knows well and in which he has experienced great success. Brian Busey also makes light work of Section 337 investigations, having handled so many in a storied career focused on the ITC. The senior counsel is a valuable strategic sounding board.


Dispensing the full suite of services via a large and well-configured team of attorneys, Oblon aligns itself as a key strategic patent partner to innovators. The boutique delivers crisp results in prosecution, the bedrock of its wider practice, taking advantage of deep familiarity with the USPTO developed over the course of thousands upon thousands of filings, examiner interviews and registrations. Assignments are carried out efficiently and cost effectively, thanks to a smart prosecution programme designed to obtain high-quality patents with the fewest office actions; this has yielded superb results, with the firm securing over 6,000 patents each year. Many of these protect chemical sciences technology – the specialist subject of PhDs Daniel Pereira, Marina Miller, Vincent Shier and Derek Mason, who form one of the best teams for the chemical industry in the entire country. Co-chair Pereira is an ace at litigation counselling and keeping clients out of trouble. Miller has litigated ANDA cases and applies contentious learnings in procuring lasting patents. Shier is highly active in Oblon’s post-grant practice, but also maintains his counselling and portfolio management skills at the highest level. Mason performs flawlessly in licensing negotiations and transactional IP scenarios. Managing partner Philippe Signore, meanwhile, anchors the electrical and mechanical prosecution group; he has lectured on US patent law around the world, gaining vital insight into international patent law and practice in the process. In litigation, Oblon continues to do good things at the ITC thanks to the diligence and quality of Eric Schweibenz: “Eric is a top expert in ITC litigation – he knows the ins and outs of Section 337 practice and has a strong enthusiasm for it. He’s super-responsive, mindful of budgets and is constantly thinking about clients’ broader objectives beyond the confines of a particular case – he understands litigation as a means to an end.” Joining him in the guide this year is litigation group co-chair Tia Fenton, who concentrates on pharmaceutical and chemical patent litigation. Together with Schweibenz, she has been representing Japan-based global food and chemical company Ajinomoto in a suit filed by Kyowa, which asserted patents relating to the process for manufacturing glutamic acid, used to make monosodium glutamate.

Paul Hastings LLP

The trial lawyers at Paul Hastings – both in DC and across its network – never blink in the spotlight of high-stakes patent infringement litigation; they maintain a clear and intense focus on themes that compel juries and triers of fact to decide things their way and have a terrific record at trial and at other litigation turning points. The firm has carved out a reputation for superiority in post-grant matters, with global vice chair of the IP group Naveen Modi driving the practice to the greatest of heights. Modi is one of, if not the most prolific PTAB attorney in the country and knows just about all there is to know about challenging and defending patents under the AIA. He and Joseph Palys have worked together for more than two decades and form a perfect partnership for complex cases in and outside the PTAB. One of their freshest victories saw the invalidation of claims of six patents for wireless phone charging asserted by NuCurrent against client Samsung Electronics – a great result in a complex, multi-layered IP dispute also involving claims for trade secret misappropriation. An authority on trade secret litigation, Jeffrey Pade was also closely involved in this one. Forming an immensely potent team with Allan Soobert and California’s Yar Chaikovsky, Modi and Palys have also been acting for Applied Materials in multiple litigations against Demaray, which is being represented by elite trial shop Irell & Manella. Soobert is a leader within the firm and the market, and someone to whom cutting-edge companies turn in times of great need. He is also acting for Samsung Electronics in an important campaign to protect its three-dimensional memory chips.

Paul Weiss Rifkind Wharton & Garrison LLP

Helping to power Paul Weiss’s undeniably brilliant patent litigation offering is a booming post-grant practice spearheaded by Steven Baughman, a consummate all-round advocate and pre-eminent PTAB specialist whose hit rate invalidating and protecting patents – including many of the most valuable assets in the world – is unsurpassed. He chalked up another win recently in upholding the validity of Chugai Pharmaceutical’s patents relating to a simpler, less costly method of purifying antibodies, with the Federal Circuit then rejecting a major pharmaceutical company’s follow-on appeals. With this and many other representations, Baughman has burnished the firm’s market-leading reputation for biologics matters. He isn’t the only big hitter in the DC office, which is also graced by the presence of litigation department co-chair Kenneth Gallo and of counsel David Ball. All three lawyers have teamed up to defend SAP in an action brought by business analytics provider Teradata alleging trade secret misappropriation and antitrust violations – the type of complex, multi-threaded, multi-forum dispute for which Paul Weiss is ever-ready.

Perkins Coie LLP

Perkins Coie assists life sciences innovators throughout all phases of the product and business lifecycle. It brings together astute prosecution and counselling lawyers – Chicago-based firmwide prosecution chair David Fournier and Palo Alto’s Viola Kung come to mind – with elite patent litigators such as IP group co-chair Shannon Bloodworth and IAM Patent 1000 newcomer Brandon White. Bloodworth is the fulcrum around which the DC IP practice turns and a seasoned lead counsel in pharmaceutical litigations for whom success in district court, PTAB and Federal Circuit cases is a recurring narrative. Propelled into the listings by widespread praise, up-and-coming partner White “is calm under pressure, provides considered strategic advice and is a talented advocate who works tirelessly to achieve the best results for his clients. He handles all aspects of his cases, including presenting arguments and testimony to district courts and administrative panels; he has especially earned the respect of PTAB judges for his ability to grasp and explain highly complex scientific concepts, and for his uncommonly clear and concise writing”. Another new face in the guide, Dan Bagatell leads the patent appeals practice. He was instrumental in obtaining a precedential decision for Hulu and Netflix in which the Federal Circuit held that the PTAB may reject proposed substitute claims in an inter partes review on eligibility grounds, even though it cannot review the patent eligibility of the original, already issued claims.

Pillsbury Winthrop Shaw Pittman LLP

Home to technically fluent lawyers, professional engineers, former USPTO examiners, patent agents and technical consultants, Pillsbury provides gold-standard assistance in prosecution. In any 12-month period, it obtains over 1,000 US patents and half that number again of foreign patents in every major theatre of innovation. Responsible for much of this activity, Ngai Zhang garners enthusiastic recommendations from the market. One client comments: “I have worked with so many IP attorneys and can say with great confidence that Ngai is by far the best of them. He dives deep into the technology, understands it, asks the right questions, grasps all the prior art and then drafts the strongest patents. He secures patents when other lawyers get nowhere. We are lucky to have him as our IP counsel.” Zhang is part of a large team of lawyers supporting UBS, which outsources its entire IP function to Pillsbury. Other members include Jack Barufka and William Atkins, both of whom are hailed for their complex problem-solving abilities. IP group lead Barufka is highly accomplished in all areas of patent practice and is adept at designing comprehensive IP strategies. Tried-and-tested trial lawyer Atkins is a master at coordinating multi-forum disputes, with a sophisticated understanding of the strategic interplay between district court litigation and PTAB proceedings. The ensemble’s post-grant practice is chaired by Patrick Doody, who is “at the very top of his game”: “Patrick defines what it means to be a professional – he has an extremely impressive depth of knowledge, tonnes of experience and great judgement and integrity. He performs at the highest level with such consistency and has a track record that inspires confidence.” Underscoring the all-inclusive nature of Pillsbury’s offering, Keeto Sabharwal and Kecia Reynolds earn inclusion in the IAM Patent 1000 as outstanding pharmaceutical and ITC litigators respectively.

Rothwell, Figg, Ernst & Manbeck, PC

There’s nothing flashy about Rothwell Figg; unswervingly dedicated to meeting clients’ needs, it executes with assurance on complex prosecution, litigation, post-grant proceedings and licensing briefs. Many of its prosecution-focused attorneys have multi-disciplinary expertise, having acted not only in a USPTO-facing capacity, but also on contentious and transactional matters – and Aydin Harston is one of them. The biochemistry PhD has seen applications through to grant hundreds of times, furnished vital support to litigation teams and represented parties before the PTAB – a diversity that has elevated his strategic thinking beyond his years. He makes his debut in the IAM Patent 1000 on the back of glowing client references: “Aydin has been a strong advocate for our company for years and prosecuted our foundational patents. Handling complex life sciences innovations, he consistently demonstrates great intelligence, professionalism, organisational skill and creativity.” A rising star in the practice, he has been working with the firm’s most senior attorney, Anthony Figg, in managing valuable patent portfolios for Biogen. Figg needs no introduction as a life sciences and litigation luminary whose strategic counsel and opinions are like gold dust. Harston and Figg also manage crown-jewel patent assets for Coherus Biosciences in collaboration with Joseph Hynds, one of the set’s best-rounded lawyers and the complete package for life sciences and high-technology players. Danny Huntington also operates at the cutting edge of developments in biotechnology and pharmaceuticals, and is successfully growing the portfolio of Editas Medicine, a leading gene editing company focused on developing CRISPR medicines. Huntington is another dynamic and versatile practitioner with a wealth of industry knowledge. Taking care of essential matters on the high-technology front, meanwhile, are Steven Weihrouch, Brian Rosenbloom and Martin Zoltick. Weihrouch has an ardent following of Japanese clients: as examples, he has obtained hundreds of patents for Tokyo Electron relating to semiconductor manufacturing equipment and dozens of patents for Suzuki Motor Corporation. Rosenbloom and Zoltick represent Ericsson in the business-aligned prosecution of patents relating to 5G wireless communications. Both have a pre-law background in software, but are quick studies when it comes to myriad technologies. They also play a key role in the ensemble’s trailblazing litigation practice and have had a hand in notable recent cases. Rosenbloom partnered with Steven Lieberman and Sharon Davis in representing CBS Corporation against Personal Audio in a complex suit: Personal Audio initially won a jury trial in the Eastern District of Texas, but its asserted patent was invalidated at the PTAB before post-trial briefing was complete; the Federal Circuit affirmed the PTAB’s decision, leading the district court to vacate the jury’s verdict. This was appealed to the Federal Circuit which, in a January 2020 decision, upheld the PTAB’s invalidation of the patent (and the Federal Circuit affirmance thereof), thus precluding Personal Audio from asserting its (now invalid) patent claims against CBS and solidifying Federal Circuit precedent on the procedural interplay between inter partes reviews and litigation. Lieberman possesses whetted trial skills and can be counted on for textbook-worthy performances. So too Davis, who is endorsed for her “masterful knowledge of the law and ability to convey complex arguments in a nuanced and effective manner”. Zoltick has been representing Nichia Corporation together with Robert Parker in an international arbitration involving a dispute with a cross-licensee and in six district court patent infringement actions. Parker gets difficult jobs done in any forum, but the ITC is a happy hunting ground: he is a former president of the ITC Trial Lawyers Association and served as counsel to the chairman of the ITC.

Sidley Austin LLP

As a trial team, Sidley can go toe to toe with any firm in the country and bring home the victories when they are needed most. Undaunted by large financial claims in competitor suits, its lawyers work with intense concentration on the dispositive issues and on devising trial strategies that shift momentum in their favour. Coordinator of the IP litigation practice Jeffrey Kushan does this masterfully in district court cases, appeals and USPTO-contested proceedings; as does Brian Nester at the ITC. Carter Phillips backs them up with pitch-perfect advocacy at the Federal Circuit and Supreme Court. From a DC perspective, securing a complete ITC victory for LONGi Solar Technology at the ITC against a competitor in the solar cell space was a particular highlight; Nester played a strong hand in this one.

Steptoe & Johnson LLP

When stellar performances are required in major ITC battles, Steptoe & Johnson steps up to provide them: its DC lawyers know the venue extremely well, having litigated there extensively and winningly. They also perform adroitly in district courts and the PTAB, making them ideally situated for complex disputes playing out across all three forums. IP group co-chair John Caracappa brings gravitas to the courtroom and is a highly effective trial team leader. He has had a busy time lately at the ITC, representing Broadcom in asserting multiple patents related to infotainment systems; securing a complete victory for Xiamen Leedarson Lighting in three investigations enabling it to freely import and sell its products in the United States; successfully settling a case for Resideo Technologies involving a patent related to the IoT; and acting for US solar technology company Solaria in an ITC matter and related district court case. With him on a number of these matters, Matthew Bathon – a former senior investigative attorney in the ITC’s Office of Unfair Import Investigations – debuts in the listings this year as a Section 337 specialist to keep firmly on the radar. In Boyd Cloern, Steptoe also has an expert for heavy-duty trade secret cases. He is currently representing Hytera Communications in a complex trade secret and copyright infringement suit in which Motorola claims that several Hytera employees misappropriated a substantial number of trade secrets and copied various portions of source code. For this, Steptoe has marshalled a potent team from its DC and other offices, capitalising on its impressively deep bench.

Sterne, Kessler, Goldstein & Fox PLLC 

The group of patent lawyers at Sterne Kessler is wonderfully cohesive: members support and learn from each other, so their advice contains the distilled essence of the firm’s incredible institutional knowledge. This encompasses all technical and scientific disciplines and everything you could possibly do with a patent – from filing to licensing and enforcing or defending it in court. The array of rankings that its lawyers achieve in the IAM Patent 1000 for 2021 bears testament to this dexterity. Making her first appearance in the guide is molecular and cellular biology PhD Deborah Sterling, whose team's recent highlights include supporting Roivant with due diligence on target assets as well as supporting Roivant subsidiary companies with complex pharmaceutical exclusivity analyses and strategies, prosecution and other tasks; Roivant builds nimble, entrepreneurial subsidiary biotech and healthcare companies with a unique talent for sourcing and incentivising approaches to develop clinical-stage assets. Sterling chairs an outstanding biotechnology and chemical group which includes the awesome Eldora Ellison, one of the nation’s foremost post-grant proceedings authorities. She serves the Regents of the University of California, whose CRISPR gene editing patent position vis-à-vis the Broad Institute – which UC is battling with over the technology – she has improved dramatically; she is also representing it as lead counsel in an interference. Ellison burns brightly as an all-round patent strategist; as do Jorge Goldstein and Eric Steffe, with whom she is acting for UC. The electronics group also engages in work of the highest order, much of it involving standout directors Donald Featherstone, Robert Sokohl, Michael Ray and Michael Lee. Featherstone couples unimpeachable foundational prosecution skills with comprehensive international knowledge and keen commercial acumen, and builds enduring relationships with clients. Sought after for prosecution, infringement and validity opinions, due diligence, post-grant proceedings and litigation, Sokohl is amazingly versatile – a boon for clients such as Capital One, which he and Sterne Kessler assist on wide-ranging matters. Cut from similar cloth, Ray sees issues in the round and can chart optimal paths forward for clients; he does this for the firm, too, in his role of managing director. Lee navigates competitive markets with an unerring compass and has been acting for Roku in the streaming space, proving highly successful at overcoming prior art and Section 101 challenges on his way to a high patent allowance rate. The mechanical and design patent group has its celebrities, too – most notably Tracy-Gene Durkin, a design patents savant for whom cutting-edge global work for Apple continues to be a major practice feature. Richard Coller comes from a biomedical engineering background and leans into multiple practices, including post-grant, litigation and appeals, which has sharpened his strategic instincts. Sterne Kessler has also been hitting home runs in major disputes recently: John Christopher Rozendaal and Michael Joffre, for example, landed a huge victory in June 2020 for Teva Pharmaceuticals, clearing the way for it to bring to market a generic version of Narcan nasal spray. Though several of Adapt Pharmaceutical’s patents survived inter partes review challenges, the guys managed to secure a finding that all four patents in suit were invalid as obvious. Daniel Yonan, the ensemble’s ITC ace, has been working with Juul on a global enforcement campaign that involves district court, ITC and overseas actions. He also prevailed for Wirtgen – the world’s largest manufacturer of road milling machines – against Caterpillar in Section 337 investigations; and arising from this, he won a US Court of International Trade suit against US Customs and the Department of Homeland Security based on unlawful interagency discussions with the ITC that led to the exclusion of a number of redesigned Wirtgen machines which had previously been allowed to enter the country. Also involved in the Juul matter, Dennies Varughese has struck gold for Amneal Pharmaceuticals at the PTAB and the Federal Circuit in challenging the validity of an Orange Book-listed patent for Almirall’s acne treatment Aczone. The appellate practice here is a strong one, with contributions coming from many and staunch leadership from Jon Wright and fellow co-chair Joffre. The overall picture at Sterne Kessler is one of excellence – much of the credit for which goes to Robert Greene Sterne, who has nourished the firm since its beginnings and instilled key attributes such as innovativeness, collaboration and big-picture thinking.

Sughrue Mion PLLC

A statistical leader in terms of patents filed and obtained, Sughrue knows how to work with the USPTO and sews up all the right protections for clients. It fields a large team of technically trained experts who effortlessly grasp the intricacies of complex technologies, operating with efficiency throughout all phases of prosecution and in post-grant actions at the PTAB, of which they handle a great many. For a key contact, look to Alan Kasper, an internationally experienced attorney with a precise handle on the state of patent law in the United States and overseas.

Venable LLP

Pioneering companies get all the patent support they need under one roof from Venable, one of the few firms with multiple representatives on each of the IAM Patent 1000’s DC prosecution, litigation and transactions tables. Calling the shots for the prosecution and counselling group, Brian Klock runs point on matters for Canon, with which Fitzpatrick – the celebrated boutique which merged into Venable in 2018 – has enjoyed an enduring relationship over several decades; given the diversity of technologies in which Canon innovates, Klock stays sharp and ready for anything. Michele Van Patten Frank supervises the group’s life sciences activities and, in providing fulsome support to clients, draws on insight from her time as an examiner and her blended patent procurement, transactions and litigation expertise. “Michele is available when you need her and always makes the time to explain matters clearly. She pushes projects forward very effectively, taking feedback in her stride and carrying herself with the utmost professionalism. She is great to partner with.” Physics PhD Henry Daley – who has also engaged in high-level contentious affairs – prosecutes in the life sciences and other areas with panache, making him a hit with several prestigious academic institutions. Turning to litigation, Frank Cimino and Megan Woodworth have been on a sparkling run of form of late. Connecting with Michele Frank, they recently acted on behalf of Viveve – a women’s health company focused on the commercialisation of a revolutionary, non-surgical medical device that remodels collagen and restores tissue – in connection with the satisfying settlement of crucial litigation against ThermiGen. They have also acted for a major automobile group at the ITC and for a leading telecommunications company in the Eastern District of Texas. Reputed for their toughness and commerciality, Cimino and Woodworth are always in hot demand. Nora Garrote and William Russell are the top IP and technology transactions specialists on deck. Diversity is the watchword for their practice: they do all kinds of deals for all kinds of companies, giving them high-level know-how that provides invaluable when breaking new ground. Garrote also serves as partner in charge of diversity and inclusion.

Weil Gotshal & Manges LLP

Weil Gotshal is no stranger to game-changing patent litigation: in fact, it’s what its IP lawyers, such as DC’s Brian Ferguson, live for. Ferguson co-heads the patent litigation practice and has been instrumental in promoting close inter-office cooperation, which is one secret of its success. A veteran enforcer and protector for some of the world’s major technology companies, he calls the right play at every stage of a case, whatever the forum. Lately he has been representing Nuance Communications in Delaware and Georgia against competitor M*Modal, in the course of which he has successfully invalidated patents in inter partes reviews. At the same time, he has been continuing his work for GE Aviation in 36 inter partes petitions challenging 30 Pratt & Whitney patents; after 15 PTAB hearings, 360 claims across 25 of the challenged patents have been invalidated and a Federal Circuit appeal has been won. A master tactician, Ferguson is well suited to such sprawling campaigns.

Williams & Connolly LLP 

“Williams & Connolly is the best patent trial outfit in the United States,” enthuses one chief IP counsel. “Its collaboration is always seamless and its success story unlimited.” This is a popularly held opinion of a firm for which high-exposure patent and licensing litigation is a daily business. Bringing together accomplished lead trial lawyers and scientific experts – there are 15 former Federal Circuit clerks in the group and 13 USPTO-registered practitioners – Williams & Connolly deploys a highly sophisticated toolkit with which it has netted groundbreaking wins in myriad life sciences and high-technology suits. The team litigates the right way too, showcasing standards that really set the bar – something that has much to do with the leadership of world-class advocate and strategist Bruce R Genderson. He has also instilled a strong team mentality which sees members of the group put ego aside and work hand in hand to get difficult jobs done. Linking up with David Berl and Dov Grossman, Genderson has been representing Bayer in ANDA litigation against Apotex over its Stivarga anti-cancer drug. Gold-ranked Berl earns plaudits for his “incredible intellect, creativity and strategic acuity”; while Grossman makes his debut in the IAM Patent 1000 and is a rising star of a group that has shown striking proficiency in developing younger talent through the delegation of responsibility and opportunity. Stanley Fisher and Jessamyn S Berniker, together with Genderson and several others, have been doing battle for Merck Sharp & Dohme in Hatch-Waxman litigation and PTAB proceedings against 14 ANDA filers seeking to produce generic versions of its diabetes drug Januvia. Berniker is ideally suited to the patent litigation co-chair role she assumed in January 2020, thanks to her instinct for leadership: inspired and motivated, her colleagues pull out all the stops. Fisher has vast biopharmaceutical experience and makes full use of his finely honed advocacy skills and intuitive understanding of Food and Drug Administration regulatory requirements and antitrust law. Contributing on the life sciences front, while also spearheading important campaigns involving high-technology, software and communications innovations, executive committee member Thomas Selby gets a lot done. Like Berniker, he has a unique ability to get the best out of those around him.

Wilmer Cutler Pickering Hale and Dorr LLP

Devastatingly effective in trials and at the Federal Circuit and Supreme Court, WilmerHale is the perfect partner for big-ticket patent litigation. It draws astutely on its resources – it is abundant in trial lawyers, appellate specialists and technical experts – to configure the optimum team for each case, ensuring it can hit the ground running and pursue the most effective strategies. Its DC lawyers are front and centre of many high-profile briefs: as an example, William McElwain was key to recent back-to-back Federal Circuit victories on behalf of Becton, Dickinson and Company and Roche against Enzo Life Sciences, in which the court unanimously affirmed a rare summary judgment ruling in the District of Delaware which invalidated the key patent asserted against his clients. David Cavanaugh and Gregory Lantier, meanwhile, obtained WilmerHale’s first final written decision in a post-grant review proceeding, on behalf of GMG Products, invalidating certain claims of a patent owned by competitor Traeger Pellet Grills. Both lawyers are recommended in the IAM Patent 1000’s national post-grant table, on which Cavanaugh – a veteran of over 250 inter partes reviews – is one among just 10 individuals. On the life sciences side, Amy Kreiger Wigmore is in the thick of things and has satisfying recent results to show for her efforts. Together with Bill Lee, she obtained a trial win for Bristol-Myers Squibb and Pfizer in litigation concerning their blockbuster Eliquis drug used to treat and reduce the risk of blood clots and the risk of stroke; initially filed against 25 different generic drug companies, the case started out as one of the largest Hatch-Waxman litigations ever. Seth Waxman is WilmerHale’s Supreme Court and appellate supremo and has been vital in cementing many of the group’s wins.

Winston & Strawn LLP 

Winston & Strawn’s prowess in the IP space is wrapped up in its incredible trial proficiency. Built to win the toughest cases, its national group of redoubtable advocates strikes hard, fast and smart, capitalising on even the smallest strategic openings; a pristine record as a defence firm places it among the elite. Sustained excellence on the life sciences side is a notable storyline: Winston is prolific in Hatch-Waxman litigation and is increasingly noted for its facility for Biologics Price Competition and Innovation Act cases – not least thanks to the sterling efforts of DC lawyers Charles Klein and Jovial Wong, who work almost telepathically both as a team and as collaborators with colleagues in other offices. Klein’s newsworthy recent activity includes a trial win for Hikma invalidating six patents for Amarin Pharma’s only drug, Vascepa, backed up at the Federal Circuit, which denied Amarin’s appeal; this will enable Hikma to launch a generic version of the hypertriglyceridemia treatment long before the patent expiration date. Wong’s resounding victories include the successful invalidation of six patents asserted in district court litigation by Huvepharma against client Associated British Foods. Winston continues to acquit itself with distinction outside of its life sciences niche – for example, at the ITC, where Thomas Jarvis and California partners Kathi Vidal and Michael Rueckheim are duking it out for Chamberlain Group against competitor Overhead Door Corporation – a dispute with a district court litigation component, too. Jarvis is a veteran Section 337 lawyer and a former senior investigative attorney who knows the ITC inside out.

Xsensus LLP 

Xsensus has a unique culture founded on the values of collaboration, respect and efficiency. Its attorneys utilise sophisticated workflow systems and technical tools to deliver a precision service emphasising electrical engineering prosecution, but recently broadening out to include post-grant proceedings, litigation and licensing, as well as life sciences and chemistry. Though only two years old, the boutique has attracted many prestigious patrons and is constantly adding to its roster; its combination of quality, personal service and cost effectiveness is proving hard to resist. Founding partners Bradley Lytle and Andrew Harry both garner warm reports. Of Lytle, one source comments: “We have huge trust in his professional skills and appreciation for his high rate of success in overcoming any rejections and prosecuting applications through to grant. His strategies are on point and his service prompt and friendly.” “Andy knows how to accelerate the prosecution process and how to build strong portfolios. He ensures there’s never any needless back and forth or paper pushing with the USPTO; he is adept at conducting examiner interviews to get to the core issues and advance matters without excess cost.” They are joined in the guide this year by Masahito Yokoyama, a fellow founder with whom they work on many projects. Yokoyama’s cross-cultural Japan-US business and IP understanding gives Xsensus a valuable added dimension.

Other recommended experts

FisherBroyles has been on a talent acquisition spree of late, with two of its most notable pick-ups being former Winston & Strawn ITC specialists Steven Anzalone and Paul Goulet. Besides the high-level trial skills that both possess, Anzalone has rich technical knowledge and Goulet deep procedural expertise. Aziz Burgy is one of the most seasoned Hatch-Waxman litigators in DC and a key cog in the dynamic life sciences patent litigation practice at Axinn. In advancing novel arguments and pressing accelerated case schedules, for example, he pulls all the levers he can with impeccable timing. Gregory Castanias captains the Federal Circuit team at Jones Day. He has persuasively argued appeals on dozens of occasions in disputes over diverse life sciences and high-technology innovations. Nixon Peabody’s Jeffrey L Costellia is intimately familiar with clients’ innovations and business objectives, and designs tight strategies around them – a benefit of the long-term relationships he forges. He’s a superb portfolio builder with extensive international connections. Michael Dilworth understands both the creative and commercial mindset and has a passion for facilitating, protecting and commercialising innovation. The Dilworth IP founder best fits the description of patent strategist: well versed in all facets of patent practice, he plays this role to perfection. A master of the chemical arts, Jacob Doughty sees the whole playing field for his and Element IP’s clients; he prosecutes, manages patent assets, gives opinions, conducts due diligence and shines in post-grant proceedings. A well-organised manager, he ensures the efficient, cost-effective delivery of high-quality work product. Appreciated for her meticulous prosecution, staunch representation in post-grant proceedings and all-round strategic savvy, Erin Dunston is a popular pick among biotechnology, pharmaceutical and medical device companies. She has settled into her digs at Panitch Schwarze nicely since joining just over a year ago. Shamita D Etienne-Cummings’ burnished technical credentials serve her well in litigation: an assured lead counsel with acute ITC expertise, she tackles high-exposure cases with confidence and poise. She serves on White & Case’s global management team. Colleague David M Tennant works miracles on USPTO-facing matters and particularly post-grant proceedings, in which he capitalises on his technical fluency, patent procurement experience and litigation know-how. Jim Gatto of Sheppard Mullin is “extremely impressive in his ability to break down technical complexity”; “he has such a strong intellect and is exceptional counselling on issues at the intersection of technology, law and business.” “The work Jim does provides his clients with a competitive advantage well into the future.” Alexander Hadjis joined Jenner & Block in January 2021, having moved on from his post at Oblon. He’s an ideal match for his new firm, thanks to his mature trial abilities. Kevin Hardy recently switched from Williams & Connolly to another elite litigation firm, Quinn Emanuel. The gifted trial lawyer has a penchant for licensing disputes. He joins Alex Lasher, the head of the ITC practice, in the firm’s DC office. Staying sharp on prosecution, DLA Piper’s James Heintz carries an advantage into patent litigation in terms of technical know-how. Colleague Joseph Lavelle is one of the firm’s pre-eminent patent trial lawyers, who adapts well between district court, ITC and Federal Circuit proceedings. Blair Jacobs recently made the switch from Paul Hastings to McKool Smith; he’s accustomed to litigating high-stakes competitor cases and is unflappable in the courtroom. Kevin B Laurence of Laurence & Phillips is a trailblazing patent strategist, seasoned PTAB lead counsel, savvy prosecutor and respected author and educator. For worldly wisdom on patent law, he’s an absolute must. His colleague, Matthew Phillips is also a respected name nationally thanks to his sterling representation in post-grant proceedings. With a sparkling track record that speaks to his technical and tactical acumen and advocacy skill, he knows how to win whether acting for patent owners or petitioners. An abundant source of insight on ITC litigation, Christine Lehman marries whetted advocacy skills with a complete command of technology; the former investigative attorney at the Office of Unfair Import Investigations is based at trial outfit Reichman Jorgensen. Few, if any practitioners in the IAM Patent 1000 have a background in music composition and theory, but Polsinelli’s Angel Lezak is one of them. She appreciates the opportunity to showcase creativity that patent practice affords and demonstrates artistry in prosecution. Noteworthy, too, is her role as a mentor to other women in the technology world. Michael Kiklis carries out all assignments with a laser business focus, including litigation and post-grant proceedings, which are his bread and butter. The Bass, Berry & Sims partner leverages broad-ranging patent experience encompassing licensing and strategic counselling and deep technical expertise to protect clients to the hilt. Patent boutique Maier & Maier guides diverse players – Fortune 500s, universities, small and medium-sized enterprises and others – through the patent process with alacrity and finesse. The architects of its personalised, accessible service are brothers Christopher Maier and Timothy Maier, for whom intellectual property is a family tradition. Excellent on the mechanics of electrical engineering prosecution, both read competitive patent landscapes accurately and provide valuable strategic advice. They also know their way around the post-grant space; though their colleague Stephen Kunin is the go-to on that front. Kunin has spent nearly five decades in the game and has a level of policy and practice knowledge that sees him called on for expert testimony. Former Oblon litigator and ITC ace Robert Mattson recently established his own self-titled boutique which offers highly specialised litigation risk assessments and insightful opinions on infringement issues. Ropes & Gray’s Scott McKeown is an undisputed leader in the post-grant space and a lawyer whom many would put in their top five PTAB attorneys. He has handled more than 300 inter partes reviews and other AIA proceedings since 2012 and in recent years has achieved many notable wins for Google. Engaged in extensive thought-leadership activity, he significantly elevates the post-grant discussion. Indranil Mukerji moved from Fish to Willkie Farr & Gallagher at the start of 2021, with responsibility for building out its high-technology patent litigation practice. Possessing sophisticated analytical and advocacy skills, he has a well-established reputation for shouldering difficult cases on behalf of industry leaders. Parker Poe trial lawyer Kyle Musgrove thrives in the cut and thrust of pharmaceutical patent litigation. A seasoned counsellor too, he sees conflicts in their wider context and has a knack for resolving them in ways that cause the least disruption to business. Scott Pivnick takes the reins of Alston & Bird’s IP litigation group in Washington DC. He’s a stirring trial team leader with wide-ranging patent, trademark and unfair competition expertise and a broad technical compass. Preliminary injunctions are hard to obtain in patent cases, but Pivnick recently secured one for client Pierce Manufacturing in a competitor spat against E-One relating to single axle quint fire trucks. Steven Routh is a veteran of dozens of trials and knows just what to do when there’s a lot on the line in court. The Orrick partner is a fellow of the American College of Trial Lawyers and has a loyal following in Asia. Perry Saidman, the founder of Saidman DesignLaw Group, practises at the cutting edge of design law in the United States and globally. He and his colleagues protect designs, set strategy and litigate guided by profound subject-matter knowledge and practical experience. Daniel Shanley undertakes high-level prosecution and strategic counselling work for prestigious patrons such as Toyota Motor Company and NICHIA Corporation. The Hunton Andrews Kurth partner is steeped in the electro-mechanical arts and maintains a global practice. Jason M Shapiro of Edell Shapiro & Finnan has been a fixture in the IAM Patent 1000 for several years. He earns his place courtesy of his exceptionally well-founded complex prosecution and post-grant proceedings capabilities, all-round strategic wisdom and commercial acumen. Greenberg Traurig’s Andrew Sommer is a confident trial team leader for patent disputes in any forum. He has an affinity for PTAB cases, of which he has handled many for both patent owners and petitioners. He has lately engaged in numerous proceedings for Satco Products against The Regents of the University of California as part of a large cross-office team the likes of which his firm is brilliant at assembling. High-powered patent litigation outfit O’Melveny & Myers maintains a strong presence at the ITC thanks to Sean Trainor, a top specialist in the forum. There he has been representing Samsung Electronics in a series of high-stakes suits filed by Dublin-based Neodron, which include multiple Western District of Texas cases. Neodron is seeking to exclude some of Samsung’s flagship Galaxy products from entry into the United States. Jeffrey Wolfson is the distinguished leader of Haynes and Boone’s patent prosecution and counselling practice. His forward-thinking approach to asset procurement and management is informed by a keen understanding of how patents are litigated, paving the way for longer-lasting protection. He takes the lead for Nabors Industries as primary patent counsel. William Zimmerman is a polished pharmaceutical patent lawyer and co-chair of the Hatch-Waxman litigation and life sciences groups at Knobbe Martens. Understanding how to get the best out of people, he runs trial teams with striking efficacy and efficiency.

Individuals: litigation

  • David J Ball Jr - Paul Weiss Rifkind Wharton & Garrison LLP
  • Steven Baughman - Paul Weiss Rifkind Wharton & Garrison LLP
  • David Berl - Williams & Connolly LLP 
  • Ruffin B Cordell - Fish & Richardson
  • Edward C Donovan - Kirkland & Ellis LLP
  • Alan M Fisch - Fisch Sigler LLP
  • Bruce R Genderson - Williams & Connolly LLP 
  • Maximilian A Grant - Latham & Watkins LLP
  • Gary M Hnath - Mayer Brown
  • J Michael Jakes - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • William G James II - Goodwin Procter LLP
  • Thomas L Jarvis - Winston & Strawn LLP
  • Charles B Klein - Winston & Strawn LLP
  • Steven Lieberman - Rothwell, Figg, Ernst & Manbeck, PC
  • Charles E Lipsey - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Gregg F LoCascio - Kirkland & Ellis LLP
  • Michael McKeon - Fish & Richardson
  • Naveen Modi - Paul Hastings LLP
  • Matthew J Moore - Latham & Watkins LLP
  • Michael A Morin - Latham & Watkins LLP
  • George F Pappas - Covington & Burling LLP
  • Adam L Perlman - Latham & Watkins LLP
  • Carter G Phillips - Sidley Austin LLP
  • Bert C Reiser - Latham & Watkins LLP
  • Matthew M Wolf - Arnold & Porter Kaye Scholer LLP
  • Steven Anzalone - FisherBroyles
  • William P Atkins - Pillsbury Winthrop Shaw Pittman LLP
  • James R Barney - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Jamie B Beaber - Mayer Brown
  • Jessamyn S Berniker - Williams & Connolly LLP 
  • Shannon Bloodworth - Perkins Coie LLP
  • Paul F Brinkman - Kirkland & Ellis LLP
  • Smith R Brittingham - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Brian M Buroker - Gibson Dunn & Crutcher LLP
  • John Caracappa - Steptoe & Johnson LLP
  • Cono A Carrano - Akin Gump Strauss Hauer & Feld LLP
  • Gregory A Castanias - Jones Day
  • Christian Chu - Fish & Richardson
  • Frank C Cimino Jr - Venable LLP
  • Joseph V Colaianni - Fish & Richardson
  • Kevin B Collins - Covington & Burling LLP
  • Mark G Davis - Goodwin Procter LLP
  • Sharon Davis - Rothwell, Figg, Ernst & Manbeck, PC
  • Erin M Dunston - Panitch Schwarze Belisario & Nadel LLP
  • Tracy-Gene G Durkin - Sterne Kessler Goldstein & Fox PLLC
  • Tara D Elliott - Latham & Watkins LLP
  • Brian E Ferguson - Weil Gotshal & Manges LLP
  • Stanley Fisher - Williams & Connolly LLP 
  • David P Frazier - Latham & Watkins LLP
  • Kenneth Gallo - Paul Weiss Rifkind Wharton & Garrison LLP
  • Lori A Gordon - Perkins Coie LLP
  • Lawrence J Gotts - Latham & Watkins LLP
  • Paul Goulet - FisherBroyles
  • Alexander J Hadjis - Jenner & Block
  • Kevin Hardy - Quinn Emanuel Urquhart & Sullivan LLP
  • Doris Johnson Hines - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Mark L Hogge - Dentons
  • M Andrew Holtman - Akin Gump Strauss Hauer & Feld LLP
  • Joseph A Hynds - Rothwell, Figg, Ernst & Manbeck, PC
  • Blair Jacobs - McKool Smith
  • William M Jay - Goodwin Procter LLP
  • Song K Jung - Dentons
  • Lisa Kattan - Baker Botts LLP
  • Robert Katz - Banner Witcoff
  • Jeffrey P Kushan - Sidley Austin LLP
  • Gregory Lantier - Wilmer Cutler Pickering Hale and Dorr LLP
  • Patrick J McCarthy - Goodwin Procter LLP
  • William G McElwain - Wilmer Cutler Pickering Hale and Dorr LLP
  • James Monroe - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Eric Namrow - Morgan Lewis & Bockius LLP
  • Brian Nester - Sidley Austin LLP
  • John O'Quinn - Kirkland & Ellis LLP
  • Ronald Pabis - Goodwin Procter LLP
  • Joseph E Palys - Paul Hastings LLP
  • Robert Parker - Rothwell, Figg, Ernst & Manbeck, PC
  • Mark A Perry - Gibson Dunn & Crutcher LLP
  • Richard Rainey - Covington & Burling LLP
  • Jay H Reiziss - McDermott Will & Emery
  • Timothy W Riffe - Fish & Richardson
  • Steven J Routh - Orrick, Herrington & Sutcliffe LLP
  • John Christopher Rozendaal - Sterne Kessler Goldstein & Fox PLLC
  • Eric W Schweibenz - Oblon
  • Thomas HL Selby - Williams & Connolly LLP 
  • Stephen Shahida - Goodwin Procter LLP
  • Stephen Smith - Cooley LLP
  • Sturgis Sobin - Covington & Burling LLP
  • Allan M Soobert - Paul Hastings LLP
  • Robert Steinberg - Latham & Watkins LLP
  • Thomas P Steindler - McDermott Will & Emery
  • Robert Greene Sterne - Sterne Kessler Goldstein & Fox PLLC
  • Einar Stole - Covington & Burling LLP
  • Seth P Waxman - Wilmer Cutler Pickering Hale and Dorr LLP
  • Amy Kreiger Wigmore - Wilmer Cutler Pickering Hale and Dorr LLP
  • Jon E Wright - Sterne Kessler Goldstein & Fox PLLC
  • Daniel E Yonan - Sterne Kessler Goldstein & Fox PLLC
  • William Zimmerman - Knobbe Martens
  • Cook Alciati - Gardella Grace PA 
  • Dan L Bagatell - Perkins Coie LLP
  • Stephen Baskin - King & Spalding LLP
  • Matthew Bathon - Steptoe & Johnson LLP
  • William Bergmann - BakerHostetler
  • Jeffrey A Berkowitz - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Aziz Burgy - Axinn, Veltrop & Harkrider LLP 
  • Chris Campbell - King & Spalding LLP
  • Alexander Chinoy - Covington & Burling LLP
  • Boyd Cloern - Steptoe & Johnson LLP
  • Ahmed Davis - Fish & Richardson
  • Lauren Degnan - Fish & Richardson
  • Bryan C Diner - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Patrick A Doody - Pillsbury Winthrop Shaw Pittman LLP
  • Dipu A Doshi - Blank Rome LLP 
  • Eldora L Ellison - Sterne Kessler Goldstein & Fox PLLC
  • Shamita D Etienne-Cummings - Allen & Overy LLP 
  • Matthew L Fedowitz - Buchanan Ingersoll & Rooney PC
  • Tia D Fenton - Oblon
  • Elizabeth D Ferrill - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael J Flibbert - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Mareesa Frederick - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Joshua Goldberg - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Dov Grossman - Williams & Connolly LLP 
  • James Heintz - DLA Piper
  • John R Hutchins - Banner Witcoff
  • Nicole M Jantzi - McDermott Will & Emery
  • Michael E Joffre - Sterne Kessler Goldstein & Fox PLLC
  • Michael L Kiklis - Bass, Berry & Sims PLC
  • Andrew Kopsidas - Fish & Richardson
  • Alex Lasher - Quinn Emanuel Urquhart & Sullivan LLP
  • Joseph Lavelle - DLA Piper
  • Lionel M Lavenue - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Christine Lehman - Reichman Jorgensen
  • Robert Mattson - Mattson IP
  • Frederic M Meeker - Banner Witcoff
  • Erik Milch - Cooley LLP
  • F Christopher Mizzo - Kirkland & Ellis LLP
  • Indranil Mukerji - Willkie Farr & Gallagher
  • C Kyle Musgrove - Parker Poe Adams & Bernstein LLP
  • Jeffrey A Pade - Paul Hastings LLP
  • Luke K Pedersen - Baker Botts LLP
  • Scott J Pivnick - Alston & Bird LLP
  • Kecia J Reynolds - Pillsbury Winthrop Shaw Pittman LLP
  • Barbara Rudolph - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • H Keeto Sabharwal - Pillsbury Winthrop Shaw Pittman LLP
  • Paul Schoenhard - McDermott Will & Emery
  • Stephen T Schreiner - Carmichael IP PLLC
  • Christopher N Sipes - Covington & Burling LLP
  • Jennifer Sklenar - Arnold & Porter Kaye Scholer LLP
  • S Lloyd Smith - Buchanan Ingersoll & Rooney PC
  • Robert E Sokohl - Sterne Kessler Goldstein & Fox PLLC
  • Andrew Sommer - Greenberg Traurig LLP
  • Rich Sterba - Fish & Richardson
  • Sanya Sukduang - Cooley LLP
  • Salvatore Tamburo - Blank Rome LLP 
  • D Sean Trainor - O’Melveny & Myers LLP
  • Jamie Underwood - Latham & Watkins LLP
  • Dennies Varughese - Sterne Kessler Goldstein & Fox PLLC
  • David Vondle - Akin Gump Strauss Hauer & Feld LLP
  • T Cy Walker - BakerHostetler
  • Steven Weihrouch - Rothwell, Figg, Ernst & Manbeck, PC
  • Mark L Whitaker - Morrison & Foerster LLP
  • Brandon White - Perkins Coie LLP
  • Jovial Wong - Winston & Strawn LLP
  • Megan S Woodworth - Venable LLP
  • Qingyu Yin - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Martin M Zoltick - Rothwell, Figg, Ernst & Manbeck, PC

Individuals: prosecution

  • Erika Harmon Arner - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Les Bookoff - Bookoff McAndrews PLLC
  • Courtenay Brinckerhoff - Foley & Lardner LLP
  • David L Cavanaugh - Wilmer Cutler Pickering Hale and Dorr LLP
  • Tracy-Gene G Durkin - Sterne Kessler Goldstein & Fox PLLC
  • Greg H Gardella - Gardella Grace PA 
  • Jorge Goldstein - Sterne Kessler Goldstein & Fox PLLC
  • John F Hayden - Fish & Richardson
  • R Danny Huntington - Rothwell, Figg, Ernst & Manbeck, PC
  • Thomas L Irving - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Song K Jung - Dentons
  • Robert Katz - Banner Witcoff
  • Michael Q Lee - Sterne Kessler Goldstein & Fox PLLC
  • David R Marsh - Arnold & Porter Kaye Scholer LLP
  • Roland G McAndrews - Bookoff McAndrews PLLC
  • Scott A McKeown - Ropes & Gray LLP
  • Mercedes K Meyer - Faegre Drinker Biddle & Reath LLP
  • W Karl Renner - Fish & Richardson
  • Michael Sartori - Baker Botts LLP
  • Mark D Sweet - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Ping Wang - Morris Manning & Martin LLP
  • Christopher Agrawal - Bookoff McAndrews PLLC
  • Hussein Akhavannik - BakerHostetler
  • MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP
  • W Todd Baker - Kirkland & Ellis LLP
  • Jack Barufka - Pillsbury Winthrop Shaw Pittman LLP
  • Jonathan Bockman - Morrison & Foerster LLP
  • James W Brady Jr - Blank Rome LLP
  • Martin A Bruehs - Dentons
  • Adriana L Burgy - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Elizabeth Burke - Jones Robb PLLC
  • Shawn B Cage - Buchanan Ingersoll & Rooney PC
  • James T Carmichael - Carmichael IP PLLC
  • Richard Chinn - Grüneberg and Myers PLLC 
  • Richard D Coller III - Sterne Kessler Goldstein & Fox PLLC
  • Jeffrey L Costellia - Nixon Peabody LLP 
  • Henry J Daley - Venable LLP
  • Ross A Dannenberg - Banner Witcoff
  • Michael Dilworth - Dilworth IP
  • Jacob A Doughty - Element IP
  • Donald J Featherstone - Sterne Kessler Goldstein & Fox PLLC
  • Matthew L Fedowitz - Buchanan Ingersoll & Rooney PC
  • Elizabeth D Ferrill - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Thomas Fiala - Fiala & Weaver PLLC
  • Michael E Fogarty - McDermott Will & Emery
  • Michele Van Patten Frank - Venable LLP
  • James G Gatto - Sheppard, Mullin, Richter & Hampton
  • Natalie J Grace - Gardella Grace PA 
  • C Gregory Gramenopoulos - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Kirsten A Grüneberg - Grüneberg and Myers PLLC 
  • Paul Gurzo - Harrity & Harrity LLP
  • Robert L Hails Jr - BakerHostetler
  • John Harrity - Harrity & Harrity LLP
  • Paul Harrity - Harrity & Harrity LLP
  • Andrew Harry - Xsensus LLP
  • Aydin Harston - Rothwell, Figg, Ernst & Manbeck, PC
  • David L Holt - Fish & Richardson
  • Nick Jepsen - Fish & Richardson
  • Kirsten Johnson - Bookoff McAndrews PLLC
  • Susanne T Jones - Jones Robb PLLC
  • David EA Jordan - Fish & Richardson
  • Alan J Kasper - Sughrue Mion PLLC
  • Patrick C Keane - Buchanan Ingersoll & Rooney PC
  • Brian L Klock - Venable LLP
  • Mark R Kresloff - Dentons
  • Phyllis K Kristal - Fish & Richardson
  • Stephen G Kunin - Maier & Maier PLLC
  • Kevin B Laurence - Laurence & Phillips IP Law 
  • Hosang Lee - Morgan Lewis & Bockius LLP
  • Angel Lezak - Polsinelli PC
  • Bradley Lytle - Xsensus LLP
  • Jill D MacAlpine - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Stephen B Maebius - Foley & Lardner LLP
  • Christopher Maier - Maier & Maier PLLC
  • Timothy J Maier - Maier & Maier PLLC
  • Frederic M Meeker - Banner Witcoff
  • Dinesh N Melwani - Bookoff McAndrews PLLC
  • Erik Milch - Cooley LLP
  • Marina I Miller - Oblon
  • Darrell G Mottley - Banner Witcoff
  • Robert G Mukai - Buchanan Ingersoll & Rooney PC
  • Eric Myers - Grüneberg and Myers PLLC 
  • Tayan Patel - BakerHostetler
  • Luke K Pedersen - Baker Botts LLP
  • Daniel J Pereira - Oblon
  • Matthew Phillips - Laurence & Phillips IP Law
  • George E Quillin - Foley & Lardner LLP
  • Timothy W Riffe - Fish & Richardson
  • Kevin D Robb - Jones Robb PLLC
  • Brian Rosenbloom - Rothwell, Figg, Ernst & Manbeck, PC
  • William C Rowland - Buchanan Ingersoll & Rooney PC
  • Thomas Rozylowicz - Fish & Richardson
  • Takashi Saito - McDermott Will & Emery
  • Daniel G Shanley - Hunton Andrews Kurth LLP
  • Jason M Shapiro - Edell Shapiro & Finnan LLC 
  • Kenneth J Sheehan - BakerHostetler
  • Vincent K Shier - Oblon
  • Philippe Signore - Oblon
  • Michele Simkin - Foley & Lardner LLP
  • Robert Smyth - Morgan Lewis & Bockius LLP
  • Stephen A Soffen - Blank Rome LLP
  • Robert E Sokohl - Sterne Kessler Goldstein & Fox PLLC
  • Eric Sophir - Foley & Lardner
  • Eric K Steffe - Sterne Kessler Goldstein & Fox PLLC
  • Deborah Sterling - Sterne Kessler Goldstein & Fox PLLC
  • C Scott Talbot - Cooley LLP
  • David M Tennant - Allen & Overy LLP 
  • Michael Tuscan - Cooley LLP
  • Todd R Walters - Buchanan Ingersoll & Rooney PC
  • Jeffrey S Weaver - Fiala & Weaver PLLC
  • Steven Weihrouch - Rothwell, Figg, Ernst & Manbeck, PC
  • Charles F Wieland III - Buchanan Ingersoll & Rooney PC
  • Jessica Winchester - Bookoff McAndrews PLLC
  • Jeffrey A Wolfson - Haynes and Boone LLP
  • Yanbin Xu - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael X Ye - Morris Manning & Martin LLP
  • Masahito Yokoyama - Xsensus LLP
  • Michael Young - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Ngai Zhang - Perkins Coie LLP
  • Martin M Zoltick - Rothwell, Figg, Ernst & Manbeck, PC

Individuals: transactions

  • Jack Barufka - Pillsbury Winthrop Shaw Pittman LLP
  • David L Cavanaugh - Wilmer Cutler Pickering Hale and Dorr LLP
  • Jeffrey L Costellia - Nixon Peabody LLP 
  • Nora E Garrote - Venable LLP
  • Jorge Goldstein - Sterne Kessler Goldstein & Fox PLLC
  • Susan E Hendrickson - Arnold & Porter Kaye Scholer LLP
  • Doris Johnson Hines - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • John Hurvitz - Covington & Burling LLP
  • Stuart Irvin - Covington & Burling LLP
  • Song K Jung - Dentons
  • D Brian Kacedon - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Patrick C Keane - Buchanan Ingersoll & Rooney PC
  • Michael Q Lee - Sterne Kessler Goldstein & Fox PLLC
  • Stephen B Maebius - Foley & Lardner LLP
  • J Derek Mason - Oblon
  • Tayan Patel - BakerHostetler
  • John C Paul - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Luke K Pedersen - Baker Botts LLP
  • William H Pratt - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael B Ray - Sterne Kessler Goldstein & Fox PLLC
  • Kristen Riemenschneider - Arnold & Porter Kaye Scholer LLP
  • William T Russell - Venable LLP
  • Adam Ruttenberg - Cooley LLP
  • Jason M Shapiro - Edell Shapiro & Finnan LLC 
  • Robert E Sokohl - Sterne Kessler Goldstein & Fox PLLC
  • Robert Greene Sterne - Sterne Kessler Goldstein & Fox PLLC
  • David M Tennant - Allen & Overy LLP 
  • Michael Tuscan - Cooley LLP
  • David Vondle - Akin Gump Strauss Hauer & Feld LLP
  • Ping Wang - Morris Manning & Martin LLP


  • G Brian Busey - Morrison & Foerster LLP
  • E Anthony Figg - Rothwell, Figg, Ernst & Manbeck, PC
  • Alan M Grimaldi - Mayer Brown
  • Perry Saidman - Saidman DesignLaw Group
  • Robert L Stoll - Faegre Drinker Biddle & Reath LLP